Past Conference
Thank you to all who attended our 13th Annual Summit for Women Leaders in Life Sciences Law in Boston
Year after year, we are humbled by and grateful for the 350+ attorneys and executives from the biotech, pharmaceutical, and medical device industries who gather to share the latest industry insights, collaborate on critical challenges, create meaningful connections, and help build this community of inspiring leaders.
Conference Co-Chairs
Elizabeth Feeney
Vice President, Assistant General Counsel
Incyte
Peena Patel
Senior Associate General Counsel
AbbVie
Lauren Ann Pond
Assistant General Counsel
BridgeBio
CEO Spotlight Interview
Arivee Vargas
CEO & Founder
Humble Rising LLC
Award Winning Author – Your Time to Rise: Unlearn Limiting Beliefs, Unlock Your Power
Former Executive Coach Program Lead – Vertex Pharmaceuticals
Lara S. Sullivan, MD
Founder & CEO
Stealth NewCo
Past CEO & Board Member, Pyxis Oncology
Founder & Past President, SpringWorks Tx
Fireside Chat with
Amy Comstock Rick
Director, Rare Disease Innovation Hub
U.S. Food and Drug Administration
Georgia Gavriilidou
Chief Legal Officer | Head of Legal Department
European Medicines Agency (EMA)
Conference Highlights
Keeping Up with the FDA’s Evolving Playbook
A deep dive into the FDA’s latest initiatives, inspection activity, and enforcement focus areas impacting drugs, devices, digital health, and life sciences industry advertising.
Harnessing AI Across the Life Sciences Industry: From Product Development to Legal Workflows and Beyond
From drug discovery and clinical trials to legal and compliance workflows, explore how AI is being deployed—and regulated—across both business and legal functions.
Navigating MFN Drug Pricing, TrumpRX, Direct-to-Patient Models, and Commercial Disruption
Analyzing the legal, regulatory, and compliance implications of alternative distribution channels, evolving pricing policies, and patient engagement models.
Life Sciences Around the Globe: Key Developments in the EU, Latin America, and Canada Impacting the Global Life Sciences Stage
Key updates on major international regulatory reforms, including the EU Pharma Package, AI Act, and evolving frameworks across Latin America and Canada.
IP Essentials for Both IP and Non-IP Lawyers
Insights into high-stakes IP disputes, practical guidance on integrating IP strategy across business and legal functions, and key IP pitfalls that non-IP attorneys in the life sciences field should have on their radar.
Managing Tariff Turbulence, Supply Chain Disruption, and the Latest Geopolitical Risks Impacting the Life Sciences Industry
Addressing the legal and operational challenges of supply chain disruption, trade policy shifts, and manufacturing strategy in a fragmenting global landscape.
Focus Sessions on Data Privacy, Cybersecurity, and Health Data Monetization
Exploring the legal complexities of leveraging clinical and real-world data, including privacy compliance, cross-border data transfers, and cyber risk management.
Spotlight on GLP-1 Drugs, Compounding, and the Wellness Economy
Navigating FDA scrutiny and emerging compliance risks in a one of the fastest-growing—and most closely watched—segments in the life sciences industry.
Download Brochure
Flip through our past conference brochure and discover the hot topics discussed.